期刊文献+

阿尔茨海默病转基因小鼠高场强磁共振影像学与病理学对照研究 被引量:1

The comparative study on high field MRI and pathology of Alzheimer's disease transgenic mice
原文传递
导出
摘要 目的 观察和分析转基因阿尔茨海默病(AD)小鼠模型早期的脑部影像学特征,确立7.0 T高场强磁共振显微成像(MRMI)对于早期AD的诊断价值.方法 3、6、9个月龄的APP/PS-1转基因小鼠各6只作为实验组,同龄野生型小鼠作为对照组;应用Bruker Phama Scan 7.0 T磁共振仪对小鼠脑部进行扫描;成像后取小鼠脑组织切片经β-淀粉样蛋白(Aβ)免疫组织化学染色,并与脑部的T2WI进行对照.结果 随着月龄的增加,APP/PS-1转基因小鼠脑部的Aβ沉积加剧,在6个月龄的APP/PS-1转基因小鼠脑部切片上已有Aβ斑块的形成,而9个月的APP/PS-1转基因小鼠皮质和海马内Aβ沉积斑块数量增多;9个月龄实验组小鼠海马及皮质可见散在点状低信号区,分布范围与病理改变相符;3、6个月龄APP/PS-1转基因小鼠及3组各月龄对照组小鼠脑组织结构T2WI未见明显低信号区.结论 与Aβ免疫组化病理结果对照,7.0T高场强MR能够显示9个月龄APP/PS-1转基因小鼠脑部的Aβ斑块沉积,有助于早期AD的诊断. Objective To observe and investigate the neuroimaging characters in early progression of transgenic Alzheimer's disease (AD) mice model, and make sure the diagnosis value of 7.0 T high field magnetic resonance microimaging(MRMI). Methods APP/PS-l transgenic mice aged 3,6, 9 months and the same aged wild type mice were each divided into 6 groups(6 mice in every groups) based on age. The mice brains were scaned with 7.0T high magnetic field MR. Then the mice were killed. The Aβ immunohistochemistry examination was analyzed in the mice brains specimens, and pathological changes were in comparison with the T2 weighted imaging in the mice brains. Results There were a few Aβ plaques in the brains of 6 months APP/PS-1 transgenic mice, while Aβ plaques were increased both in number and volume in the cerbral cortex and hippocampus of 9 months AD mice. The brains of APP/PS-1 double transgenic mice of 3, 6 months and the control group mice were not showed intensity loss on T2 weighted MR images, while the signal intensity loss was visualized in the cerbral cortex and hippocampus of 9 months AD mice. Conclusion 7. 0T high magnetic field MR could display Aβ plaques in the brains of APP/PS-1 double transgenic mice of 9 months and it is helpful to diagnosis early AD.
出处 《中华医学杂志》 CAS CSCD 北大核心 2011年第13期876-879,共4页 National Medical Journal of China
关键词 阿尔茨海默病 磁共振成像 淀粉样Β蛋白 模型 动物 Alzheimer's disease Magnetic resonance imaging Amyloid beta-protein Models, animal
  • 相关文献

参考文献19

  • 1张振馨,王新德,陈清棠,舒良,王纪佐,单广良.石杉碱甲治疗阿尔茨海默病的有效性和安全性的多中心双盲随机对照试验[J].中华医学杂志,2002,82(14):941-944. 被引量:68
  • 2Mirra SS,Hart MN,Terry RD.Making the diagnosis of Alzheimer's disease.A primer for practicing pathologists.Arch Pathol Lab Med,1993,117:132-144.
  • 3Blennow K,de Leon MJ,Zetterberg H.Alzheimer's disease.Lancet,2006,368:387-403.
  • 4Jagust W.Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia.Alzheimer's Dementia,2006,2:36-42.
  • 5Devanand DP,Pradhaban G,Liu X,et al.Hippocampal and entorhinal atrophy in mild cognitive impairment:prediction of Alzheimer disease.Neurology,2007,68:828-836.
  • 6王涛,肖世富,李霞,朱敏捷,郝晶,丁蓓,凌华威,陈克敏.阿尔茨海默病患者脑体积变化二年随访对照研究[J].中华医学杂志,2008,88(15):1027-1031. 被引量:3
  • 7Samura E,Shoji M,Kawarabayashi T,et al.Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.Brain Res,2006,1094:192-199.
  • 8Gordon MN,Holcomb LA,Jantzen PT,et al.Time course of the development of Alzheimer-like pathology in the doubly transgenic PSl + APP mouse.Exp Neurol,2002,173:183-195.
  • 9Mrak RE,Sheng JG,Griffin WS,et al.Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.J Neuropathol Exp Neurol,1996,55:273-279.
  • 10Jankowsky JL,Fadale DJ,Anderson J,et al.Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo:evidence for augmentation of a 42-specific gamma secretase.Hum Mol Genet,2004,13:159-170.

二级参考文献7

共引文献82

同被引文献18

  • 1Rouhl RP, Damoiseaux JG, Lodder J, et al. Vascular inflammation in cerebral small vessel disease. Neurobiol Aging, 2012, 33(8): 1800-1806.
  • 2Basak JM, Verghese PB, Yoon H, et al. Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Abeta uptake and degradation by astrocytes. J Biol Chem, 2012, 287(17): 13959-13971.
  • 3McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 2011, 7( 3): 263- 269.
  • 4Adams HH, Cavalieri M, Verhaaren BF, et al. Rating method for dilated Virchow-Robin spaces on magnetic resonance imaging. Stroke, 2013, 44(6): 1732-1735.
  • 5Ramirez J, Berezuk C, McNeely AA, et al. Visible Virchow-Robin spaces on magnetic resonance imaging of Alzheimer's disease patients and normal elderly from the sunnybrook dementia study. J Alzheimer Dis, 2015, (43): 415-424.
  • 6Nishitsuji K, Hosono T, Uchimura K, et al. Lipoprotein lipase is a novel amyloid beta (Abeta) binding protein that promotes glycosaminoglycan dependent cellular uptake of Abeta in astrocytes. J Biol Chem, 2011,286(8): 6393-6401.
  • 7Chen W, Song X, Zhang Y, et al. Assessment of the Virchow-Robin spaces in Alzheimer disease, mild cognitive impairment and normal aging, high-field mr imaging. AJNR Am J Neuroradiol, 2011, 32(8): 1490-1495.
  • 8Rouhl RP, Damoiseaux JG, Lodder J, et al. Vascular inflammation in cerebral small vessel disease. Neurobiol Aging, 2012, 33(8):1800-1806.
  • 9Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: how to move forward? Neurology, 2009, 72(4): 368-374.
  • 10Mawuenyega KG, Sigurdson W, Ovod V, et al. Decreased clearance of CNS beta-amyloid in Alzheimers disease. Science, 2010, 330(6012): 1774.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部